John Taylor

Enzyme-replacement therapy in life-threatening hypophosphatasia.

Nick Bishop, José Luis Millán, Matthew Downs, 2012, The New England journal of medicine.

Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial.

N. Bishop, W. Mcalister, M. Whyte, 2019, The lancet. Diabetes & endocrinology.

Heparin lock intravenous line. Use in newborn infants. A controlled trial.

H. Kilbride, J. Taylor, R. Shannon, 1989, Clinical pediatrics.

Enzyme-replacement therapy in life-threatening hypophosphatasia.

J. Millán, N. Bishop, C. Greenberg, 2012, The New England journal of medicine.